Hesperos

Hesperos, Inc. is a leader in characterizing individual biology through the Human-on-a-Chip microfluidic system. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this field, from single organ chip structures to fully functional, interconnected multi-organ systems. With the mission to revolutionize efficacy evaluation in toxicology testing and drug discovery, the company has developed a pump-free platform with serum-free cell culture medium, allowing multi-organ system communication and integrated computational PKPD modeling of live physiological responses using neuronal function readouts, cardiac, muscle, barrier tissues, neuromuscular junctions, and responses from liver, pancreas, and barrier tissues.Hesperos, Inc.'s mission is to accelerate drug discovery through the use of scalable multi-organ microphysiological systems (also known as: Human-on-a-Chip®), which provide analytical services for the pharmaceutical, cosmetics, and food industries. These services enable research teams to determine how the human body will respond when new drug compounds are introduced—something that previously required expensive animal and human trials to ascertain. The Hesperos system will reduce drug development costs and bring better treatments to patients at an unprecedented speed, all without the need for animal testing.